Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Director/PDMR Shareholding

12 Dec 2017 08:32

RNS Number : 0603Z
Wolf Minerals Limited
12 December 2017
 

12 December 2017

WOLF MINERALS LIMITED

("WLFE" or the "Company")

DIRECTOR SHAREHOLDING

Wolf Minerals Limited (AIM: WLFE), has today issued to Mr Richard Lucas, Interim Managing Director, 3,104,637 performance rights as approved by shareholders on 28 November 2017 under the Performance Rights Plan. Subject to the attainment of vesting conditions (details of which are in the Notice of Meeting released on 20 October 2017), the performance rights convert to Wolf Minerals Limited Ordinary Shares on a one for one basis.

 

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated Reason for the notification

 

a)

Name

Richard Lucas

 

 

2

Reason for the notification

 

a)

Position/status

Interim Managing Director

 

 

b)

Initial notification

/Amendment

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Wolf Minerals Limited

 

b)

LEI

213800F9EQEDKGDKZM06

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of  the financial instrument, type of instrument

 

 

Identification code

 

Performance rights which convert to Wolf Minerals Limited Ordinary Shares on a one for one basis if vesting conditions are met.

 

ISIN Code of Wolf Minerals Limited Ordinary Shares: AU000000WLF3

 

 

b)

Nature of the transaction

Issue of Performance Rights under the Company's long term incentive plan known as the Performance Rights Plan ("PRP") in accordance with the interim Managing Director's, Mr Richard Lucas, contract of employment and the subsequent issue of Performance Rights by the Company to Mr Lucas, on 12 December 2017 following approval by shareholders at the Company's Annual General Meeting on 28 November 2017.

c)

Price(s) and volume(s)

 

 

 

 

 

 

Prices

Volumes

A$ 0.0865

(equivalent to ~5p)

3,104,637

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

3,104,637 performance rights

 

AUD  $268,500

e)

Date of the transaction

12 December 2017

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFFWSWEFWSEFE
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSAppendix 5B
28th Apr 20177:00 amRNSQuarterly Activities Report
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
4th Apr 20177:00 amRNSAppendix 3Y
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.